# Early Discontinuation of Prophylactic Antibiotics Is Not Associated with Increased Surgical Site Infection Risk in Spine Surgery: A Nationwide Cohort Study

**Authors:** Sangjun Park, Jun-Seok Lee, Young-Hoon Kim, Sang-Il Kim, Youngjin Kim, Sukil Kim, Hyung-Youl Park

PMC · DOI: 10.3390/antibiotics15030272 · Antibiotics · 2026-03-06

## TL;DR

Stopping antibiotics within 24 hours after spine surgery does not increase infection risk, while longer use may raise it.

## Contribution

Nationwide data shows early antibiotic discontinuation in spine surgery is safe and reduces infection risk.

## Key findings

- Early antibiotic discontinuation (<24 h) was linked to lower surgical site infection rates.
- Prolonged antibiotic use (≥24 h) increased odds of surgical and non-surgical site infections.
- Results support guidelines limiting prophylactic antibiotics to 24 hours in spine surgery.

## Abstract

Background/Objectives: Surgical site infection (SSI) remains a significant complication following spine surgery, yet the optimal duration of prophylactic antibiotic administration remains debated. We investigated the association between prophylactic antibiotic duration and SSI rates following spine surgery using a nationwide claims database. Methods: This retrospective cohort study analyzed data from the Health Insurance Review and Assessment Service quality assessment database across four assessment waves (2014–2020, sixth to ninth). Adult patients (aged ≥19 years) undergoing elective spine surgery (decompression, instrumented fusion, vertebroplasty, or kyphoplasty) were categorized into two groups based on prophylactic antibiotic duration: <24 h or ≥24 h. Surgery type was the primary surgical categorization, while surgery site (cervical, thoracic, lumbar) was assessed separately in supplemental analyses. Primary outcomes included SSI, non-surgical-site infections, and total postoperative infections within 3 months. Multivariable logistic regression was performed to identify independent predictors of infection. Results: Of 82,840 patients included, 19,988 (24.1%) discontinued prophylactic antibiotics within 24 h and 62,852 (75.9%) continued antibiotics for ≥24 h. The <24 h group demonstrated significantly lower SSI rates compared to the ≥24 h group (0.16% vs. 1.47%, p < 0.05). After adjustment for confounders, prolonged antibiotic prophylaxis (≥24 h) was associated with increased odds of SSI (adjusted odds ratio [aOR] = 10.73, 95% CI = 7.30–15.79), non-surgical-site infections (aOR = 16.06, 95% CI = 13.11–19.67), and total postoperative infections (aOR = 17.82, 95% CI = 14.83–21.42). Conclusions: In this nationwide cohort, early discontinuation of prophylactic antibiotics within 24 h was not associated with increased SSI risk. Prolonged antibiotic prophylaxis beyond 24 h was associated with higher SSI rates, although confounding by indication likely contributed to this finding. These results are consistent with current guideline recommendations for limiting prophylactic antibiotic duration to 24 h or less in routine spine surgery, while recognizing that individualized approaches may be warranted in some high-risk patients.

## Full-text entities

- **Diseases:** infectious disease (MESH:D003141), fever (MESH:D005334), hypertension (MESH:D006973), allergies (MESH:D004342), site (MESH:D009371), acute kidney injury (MESH:D058186), erythema (MESH:D004890), tenderness (MESH:D063806), pain (MESH:D010146), skin or soft tissue infection (MESH:D018461), DM (MESH:D003920), injury to (MESH:D014947), Infection (MESH:D007239), postoperative (MESH:D019106), SSI (MESH:D013530), malnutrition (MESH:D044342), abscess (MESH:D000038), antibiotic allergies (MESH:D004761), Obesity (MESH:D009765), comorbidity (MESH:D004194), C. difficile infection (MESH:D003015)
- **Chemicals:** cefazolin (MESH:D002437), cephalosporin (MESH:D002511), aminoglycosides (MESH:D000617), vancomycin (MESH:D014640)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** PC23ZISI0031 — Homo sapiens (Human), Werner syndrome, Induced pluripotent stem cell (CVCL_IN37)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13023957/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13023957/full.md

## References

47 references — full list in the complete paper: https://tomesphere.com/paper/PMC13023957/full.md

---
Source: https://tomesphere.com/paper/PMC13023957